ArticleViruses2024

Anti SARS-CoV-2 Monoclonal Antibodies in Pre-Exposure or Post-Exposure in No- or Weak Responder to Vaccine Kidney Transplant Recipients: Is One Strategy Better than Another?

Anais Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.